Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Biliary Tract Diseases

  Free Subscription


Articles published in Gastroenterology

Retrieve available abstracts of 76 articles:
HTML format



Single Articles


    August 2026
  1. GUTIERREZ SA, Westerhoff M, Machicado JD
    New-Onset Biliary Strictures in a Patient With IBD: Not Always PSC.
    Gastroenterology. 2026 Aug 10:S0016-5085(26)07153.
    PubMed    


  2. CHAZOUILLERES O, Bellet J, Schramm C, Trivedi P, et al
    Prognostic performance of liver stiffness measurements in primary sclerosing cholangitis: the prospective FICUS cohort.
    Gastroenterology. 2026 Aug 4:S0016-5085(26)07125.
    PubMed     Abstract available


    July 2026
  3. BRACONI C, O'Rourke CJ, Andersen JB, Roberts LR, et al
    Molecular Subtypes of Cholangiocarcinoma and their Translational Implications.
    Gastroenterology. 2026 Jul 13:S0016-5085(26)07040.
    PubMed     Abstract available


    May 2026
  4. HUANG J, Wang M, Liu J, Liu F, et al
    Beyond Pancreatitis: What Primary EUS-CDS Means for Surgery and Patient-Centered Outcomes.
    Gastroenterology. 2026 May 9:S0016-5085(26)06838.
    PubMed    


  5. GORNALS JB, Perez-Miranda M, Loras C
    EUS-choledochoduodenostomy with LAMS: Here to Stay, but All That Glitters Is Not Gold.
    Gastroenterology. 2026 May 8:S0016-5085(26)06842.
    PubMed    


  6. CHEN J, Huang Y, Xu X, Weng D, et al
    Pancreatic Duct Stenting and Interpretation of the ERCP Comparator Arm in Malignant Distal Biliary Obstruction.
    Gastroenterology. 2026 May 8:S0016-5085(26)06839.
    PubMed    


  7. LI JS, Li ZS, Liu F
    EUS-Guided Choledochoduodenostomy Versus ERCP for the Primary Prevention of Pancreatitis: An Unfair Comparison.
    Gastroenterology. 2026 May 8:S0016-5085(26)06841.
    PubMed    


  8. JACQUES J, Albouys J, Chen YI
    EUS-guided choledochoduodenostomy instead of ERCP as first-line biliary drainage: what are the remaining barriers to wider adoption?
    Gastroenterology. 2026 May 8:S0016-5085(26)06840.
    PubMed    


  9. VUPPALANCHI R, Bergquist A
    Molecular Eyes on the Bile Duct: Next-Generation Sequencing Earns Its Place in Biliary Stricture Evaluation.
    Gastroenterology. 2026 May 8:S0016-5085(26)06836.
    PubMed    


  10. SPADACCINI M, Fabbri C, Anderloni A
    Not all gold, yet still a valuable option: EUS-guided choledochoduodenostomy as first-line drainage in dilated bile ducts.
    Gastroenterology. 2026 May 8:S0016-5085(26)06845.
    PubMed    


  11. GAO Y, Wang X, Yang Y
    EUS-CDS in Malignant Distal Biliary Obstruction: Moving Beyond Technical Success Toward Personalized Patient Selection.
    Gastroenterology. 2026 May 8:S0016-5085(26)06844.
    PubMed    


  12. DHAR J, Samanta J
    EUS-guided choledochoduodenostomy or ERCP for distal malignant obstruction: the debate continues.
    Gastroenterology. 2026 May 8:S0016-5085(26)06843.
    PubMed    


  13. BOUCHIBA H, Bastiaansen BAJ, Dekker E
    An unusual biliary manifestation in a patient with familial adenomatous polyposis: What is your diagnosis?
    Gastroenterology. 2026 May 2:S0016-5085(26)06829.
    PubMed    


    April 2026
  14. HOWARTH M, James M, Lam NN, Dixon E, et al
    Multi-center Prospective Evidence of Kidney Safety of NSAIDs for Prevention of Post-ERCP Pancreatitis.
    Gastroenterology. 2026 Apr 20:S0016-5085(26)00348.
    PubMed    


    March 2026
  15. DAS R, Kleinberger J, Sawas T, Wald AI, et al
    DNA/RNA-Based Next-Generation Sequencing (NGS) Improves the Early Diagnosis and Management of Neoplastic Bile Duct Strictures: A Six-Year, Prospective, Multi-Institutional, Real-Time Study.
    Gastroenterology. 2026 Mar 27:S0016-5085(26)00252.
    PubMed     Abstract available


    February 2026
  16. ELMUNZER BJ, Winslow E, De Giorgio R, Laghi A, et al
    Gallbladder and Sphincter of Oddi Disorders.
    Gastroenterology. 2026 Feb 17:S0016-5085(26)00124.
    PubMed     Abstract available


  17. DI LORENZO C, Saps M, Chumpitazi BP, Rajindrajith S, et al
    Lower and Biliary Disorders of Gut-Brain Interaction: Child/Adolescent.
    Gastroenterology. 2026 Feb 17:S0016-5085(26)00125.
    PubMed     Abstract available


    January 2026
  18. ANDERLONI A, Spadaccini M, Binda C, Mauro A, et al
    Endoscopic Ultrasound-Guided Choledochoduodenostomy vs Endoscopic Retrograde Cholangiopancreatography in Malignant Distal Biliary Obstruction to Prevent Postprocedural Pancreatitis: A Randomized Trial.
    Gastroenterology. 2026 Jan 9:S0016-5085(25)05982.
    PubMed     Abstract available


    October 2025
  19. FOX D, Xie J, Burwinkel JL, Adams JM, et al
    Adeno-associated Virus-mediated Silencing of Sox4 Leads to Long-Term Amelioration of Liver Phenotypes in Mouse Models of Alagille Syndrome.
    Gastroenterology. 2025;169:1000-1016.
    PubMed     Abstract available


    August 2025
  20. HO MH, Yang CW, Chen YG
    An occult etiology behind the episode of obstructive jaundice in a young woman.
    Gastroenterology. 2025 Aug 28:S0016-5085(25)05924.
    PubMed    


  21. YE J, Gong Y, Zhu C
    An Unusual Case of Fever and Biliary Dilatation in an Adult.
    Gastroenterology. 2025 Aug 1:S0016-5085(25)05838.
    PubMed    


  22. ROBLES-MEDRANDA C, Verpalen I, Schulz D, Spadaccini M, et al
    Artificial Intelligence in Biliopancreatic Disorders: Applications in Cross-Sectional Imaging and Endoscopy.
    Gastroenterology. 2025;169:471-486.
    PubMed     Abstract available


    July 2025
  23. ACKERMANN O, Bernard O, Franchi-Abella S, Almes M, et al
    The natural history of gastroesophageal varices in children with portal hypertension.
    Gastroenterology. 2025 Jul 15:S0016-5085(25)05748.
    PubMed     Abstract available


    June 2025
  24. PAL P, Marri UK, Reddy DN
    A Curious Culprit Behind Biliary Pus: What's the Diagnosis?
    Gastroenterology. 2025 Jun 13:S0016-5085(25)00892.
    PubMed    


  25. WANG Q, Jia J, Zhao X
    An Unusual Cause of Secondary Sclerosing Cholangitis: A Case Report.
    Gastroenterology. 2025 Jun 2:S0016-5085(25)00836.
    PubMed    


    May 2025
  26. YIZI H, Haifeng H, Yongzhi X
    Comments on "Adverse Events Associated With Endoscopic Retrograde Cholangiopancreatography: Systematic Review and Meta-Analysis".
    Gastroenterology. 2025 May 2:S0016-5085(25)00657.
    PubMed    


  27. YANG L, Tang J, Yang C, Liu G, et al
    Endoscopic Retrograde Cholangiopancreatography-Related Adverse Events: Reflections on Indication Criteria and Data Accuracy.
    Gastroenterology. 2025 May 2:S0016-5085(25)00656.
    PubMed    


  28. MAHAPATRA SJ, Freeman ML, Garg PK
    Endoscopic Retrograde Cholangiopancreatography-Associated Risk of Death: How to Interpret and Mitigate?
    Gastroenterology. 2025 May 2:S0016-5085(25)00658.
    PubMed    


    March 2025
  29. HAEUSLER R, DeBosch BJ
    Beyond scratching the surface: a non-pruritogenic novel bile acid derivative that ameliorates cholestatic- and diet-induced liver injury.
    Gastroenterology. 2025 Mar 6:S0016-5085(25)00482.
    PubMed    


    November 2024
  30. LIU Y, Zhu P, Xiang H
    A Case of Cholestasis in an Adult Male: The Mystery of a Long-Unresolved Condition.
    Gastroenterology. 2024 Nov 28:S0016-5085(24)05749.
    PubMed    


  31. BISHAY K, Meng ZW, Khan R, Gupta M, et al
    Adverse Events Associated with Endoscopic Retrograde Cholangiopancreatography: Systematic Review and Meta-analysis.
    Gastroenterology. 2024 Nov 6:S0016-5085(24)05657.
    PubMed     Abstract available


  32. DORNER H, Stolzer I, Mattner J, Kaminski S, et al
    Gut Pathobiont-Derived Outer Membrane Vesicles Drive Liver Inflammation and Fibrosis in Primary Sclerosing Cholangitis-Associated Inflammatory Bowel Disease.
    Gastroenterology. 2024;167:1183-1197.
    PubMed     Abstract available


    October 2024
  33. MOLLESTON JP, Goodrich NP, Ye W, Leung DH, et al
    Prospective Analysis of Liver Stiffness Measurement by Vibration Controlled Transient Elastography as a Predictor of Outcomes in Biliary Atresia.
    Gastroenterology. 2024 Oct 17:S0016-5085(24)05573.
    PubMed    


    September 2024
  34. FORBES N
    EUS-guided Rendezvous versus Needle-knife Sphincterotomy Following Difficult Biliary Cannulation in ERCP for Benign Disease.
    Gastroenterology. 2024 Sep 13:S0016-5085(24)05466.
    PubMed    


    August 2024
  35. SMITH N, Borowsky J, Thomas JA
    Expanding the diagnostic toolkit in chronic cholestasis.
    Gastroenterology. 2024 Aug 10:S0016-5085(24)05331.
    PubMed    


    July 2024
  36. XIE D, Qian B
    Endoscopic transpapillary gallbladder stenting prevents recurrent cholecystitis: are the benefits the same in patients with or without common bile duct stone?
    Gastroenterology. 2024 Jul 17:S0016-5085(24)05215.
    PubMed    


  37. GOYAL MK
    Comments on "Endoscopic Gallbladder Stenting to Prevent Recurrent Cholecystitis in Deferred Cholecystectomy: A Randomized Trial".
    Gastroenterology. 2024 Jul 16:S0016-5085(24)05216.
    PubMed    


    June 2024
  38. COSGRAVE C, Shembrey J, Dowling D
    A curious case of cholestatic liver injury.
    Gastroenterology. 2024 Jun 27:S0016-5085(24)05117.
    PubMed    


  39. VENKATESWARAN N
    Seladelpar as an alternate second line agent for Primary Biliary Cirrhosis.
    Gastroenterology. 2024 Jun 20:S0016-5085(24)05064.
    PubMed    


  40. HSU BY, Driscoll J, Tateno C, Mattis AN, et al
    Human Hepatocytes Can Give Rise To Intrahepatic Cholangiocarcinomas.
    Gastroenterology. 2024 Jun 10:S0016-5085(24)05028.
    PubMed    


    May 2024
  41. WANG R, Li B, Huang B, Li Y, et al
    Gut microbiota-derived butyrate induces epigenetic and metabolic reprogramming in myeloid-derived suppressor cells to alleviate primary biliary cholangitis.
    Gastroenterology. 2024 May 27:S0016-5085(24)04936.
    PubMed     Abstract available


  42. CHANG M, Hammami MB, Sakiani S
    A Case of Hepatobiliary Challenges: Unraveling the Mystery of Bile Duct Disappearance.
    Gastroenterology. 2024 May 14:S0016-5085(24)04914.
    PubMed    


    February 2024
  43. KHROM M, Long M, Dube S, Robbins L, et al
    Comprehensive association analyses of extraintestinal manifestations in inflammatory bowel disease.
    Gastroenterology. 2024 Feb 27:S0016-5085(24)00232.
    PubMed     Abstract available


  44. LENS S
    In Search of the Best Second-Line Therapy for Primary Biliary Cholangitis.
    Gastroenterology. 2024 Feb 20:S0016-5085(24)00185.
    PubMed    


  45. RIDTITID W, Karuehardsuwan J, Faknak N, Piyachaturawat P, et al
    Endoscopic gallbladder stenting to prevent recurrent cholecystitis in deferred cholecystectomy: a randomized trial.
    Gastroenterology. 2024 Feb 13:S0016-5085(24)00169.
    PubMed     Abstract available


  46. TRIVEDI PJ, Hirschfield GM, Adams DH, Vierling JM, et al
    Immunopathogenesis of Primary Biliary Cholangitis, Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Themes and Concepts.
    Gastroenterology. 2024 Feb 9:S0016-5085(24)00165.
    PubMed     Abstract available


    December 2023
  47. LEWINSKA M, Zhuravleva E, Satriano L, Martinez MB, et al
    Fibroblast-derived lysyl oxidase increases oxidative phosphorylation and stemness in cholangiocarcinoma.
    Gastroenterology. 2023 Dec 12:S0016-5085(23)05594.
    PubMed     Abstract available


    November 2023
  48. JIANG X, Otterdal K, Chung BK, Maucourant C, et al
    Cholangiocytes modulate CD100 expression in the liver and facilitate pathogenic Th17 differentiation.
    Gastroenterology. 2023 Nov 21:S0016-5085(23)05508.
    PubMed     Abstract available


  49. XIE R, Zhou B, Ding X
    Macroamylasemia or Cholecystitis: What is the Culprit of Abdominal Pain?
    Gastroenterology. 2023 Nov 3:S0016-5085(23)05209.
    PubMed    


  50. ALBRECHT T, Rossberg A, Albrecht JD, Nicolay JP, et al
    Deep Learning-Enabled Diagnosis of Liver Adenocarcinoma.
    Gastroenterology. 2023;165:1262-1275.
    PubMed     Abstract available


    October 2023
  51. CHEN VH, Jiang SX, Ko HH
    A Rare Cause of Cholestatic Liver Enzyme Elevation from a Common Entity.
    Gastroenterology. 2023 Oct 13:S0016-5085(23)05134.
    PubMed    


  52. BUN AY
    Reply to Letters to the Editor on the Article "EUS-Guided Choledocho-duodenostomy Using Lumen Apposing Stent Versus ERCP With Covered Metallic Stents in Patients With Unresectable Malignant Distal Biliary Obstruction: A Multicenter Randomized Controll
    Gastroenterology. 2023 Oct 6:S0016-5085(23)05082.
    PubMed    


    September 2023
  53. MANFREDI GF, Pinato DJ
    Inflammation as a pathogenic mechanism of colonic neoplasia in primary sclerosing cholangitis.
    Gastroenterology. 2023 Sep 28:S0016-5085(23)05066.
    PubMed    


  54. VAN DELFT F, de Jong MJ
    Patency rates of biliary stents: context is crucial.
    Gastroenterology. 2023 Sep 14:S0016-5085(23)05007.
    PubMed    


  55. BUXBAUM JL, Vogelaar IL
    Are the "ELEMENTS" Fulfilled for Adoption of EUS-Guided Choledochoduodenostomy as a First-Line Modality?
    Gastroenterology. 2023 Sep 4:S0016-5085(23)04973.
    PubMed    


  56. FLIGOR SC, Tsikis ST, Hirsch TI, Pan A, et al
    A Medium-Chain Fatty Acid Analogue Prevents Intestinal Failure-Associated Liver Disease in Preterm Yorkshire Piglets.
    Gastroenterology. 2023;165:733-745.
    PubMed     Abstract available


    August 2023
  57. SCHERER D, Boekstegers F, Bermejo JL
    Reply to the Letters to the Editor on the article "Gallstones, Cholecystectomy, and Kidney Cancer: Observational and Mendelian Randomization Results Based on Large Cohorts".
    Gastroenterology. 2023 Aug 21:S0016-5085(23)04897.
    PubMed    


  58. LI JS, Tang J, Liu F
    EUS-guided choledochoduodenostomy using lumen-apposing metal stents vs. ERCP: Further efforts are required.
    Gastroenterology. 2023 Aug 19:S0016-5085(23)04894.
    PubMed    


  59. CALDERON LP, Strasser O, Brant A
    Comment Regarding "Gallstones, Cholecystectomy, and Kidney Cancer: Observational and Mendelian Randomization Results Based on Large Cohorts".
    Gastroenterology. 2023 Aug 7:S0016-5085(23)04881.
    PubMed    


  60. CHEN YI, Sahai A, Donatelli G, Lam E, et al
    Endoscopic ultrasound-guided biliary drainage of first intent with a lumen-apposing metal stent vs. endoscopic retrograde cholangiopancreatography in malignant distal biliary obstruction: a multicenter randomized controlled study (ELEMENT trial).
    Gastroenterology. 2023 Aug 5:S0016-5085(23)04877.
    PubMed     Abstract available


    July 2023
  61. FONSECA CHEBLI JM, Akkari Evangelista RK, Chebli LA
    Persistent constitutional symptoms and cholestasis during anti-TNF therapy as a harbinger of a surprising condition.
    Gastroenterology. 2023 Jul 23:S0016-5085(23)04787.
    PubMed    


  62. CHINITZ MA
    Comment on "Gallstones, Cholecystectomy, and Kidney Cancer: Observational and Mendelian Randomization Results Based on Large Cohorts".
    Gastroenterology. 2023 Jul 17:S0016-5085(23)04775.
    PubMed    


    June 2023
  63. KARIM MM, Parkash O
    Prolonged Endoscopic Retrograde Cholangiography Cannulation Step-up Protocol Likely Causing Longer Procedure Time: A Major Confounding Factor.
    Gastroenterology. 2023 Jun 23:S0016-5085(23)00882.
    PubMed    


  64. FRITZSCHE JA, van Wanrooij RL, Voermans RP
    EUS-guided choledochoduodenostomy; taking the shortcut, but still a long way to go.
    Gastroenterology. 2023 Jun 6:S0016-5085(23)00824.
    PubMed    


    May 2023
  65. CHAVAN R, Baraldo S, Rajput S
    Inclusion of Patients with Duodenal Obstruction in Endoscopic Retrograde Cholangiopancreatography Group: Not a Right Intention.
    Gastroenterology. 2023 May 14:S0016-5085(23)00733.
    PubMed    


  66. LINN YL, Lim EKW
    A Very Unusual Complication of Groove Pancreatitis.
    Gastroenterology. 2023;164:e21-e23.
    PubMed    


    April 2023
  67. TEOH AYB, Napoleon B, Kunda R, Arcidiacono PG, et al
    EUS - guided choledocho-duodenostomy using lumen apposing stent versus ERCP with covered metallic stents in patients with unresectable malignant distal biliary obstruction. A multi-center randomized controlled trial. (DRA-MBO trial).
    Gastroenterology. 2023 Apr 28:S0016-5085(23)00630.
    PubMed     Abstract available


  68. BOUSABA J, Torres M, Dilmaghani S, Harmsen WS, et al
    EFFECTS OF FGF19 ANALOG ALDAFERMIN IN PATIENTS WITH BILE ACID DIARRHEA: A RANDOMIZED, PLACEBO-CONTROL TRIAL.
    Gastroenterology. 2023 Apr 19:S0016-5085(23)00621.
    PubMed    


  69. KANG JH, Splinter PL, Trussoni CE, Pirius NE, et al
    The epigenetic reader, BRD2, mediates cholangiocyte senescence via interaction with ETS1.
    Gastroenterology. 2023 Apr 12:S0016-5085(23)00592.
    PubMed     Abstract available


  70. KHARAZMI E, Scherer D, Boekstegers F, Liang Q, et al
    Gallstones, cholecystectomy and kidney cancer: observational and Mendelian randomisation results based on large cohorts.
    Gastroenterology. 2023 Apr 11:S0016-5085(23)00580.
    PubMed     Abstract available


    March 2023
  71. NOMDEN M, Kuipers F, Hulscher JBF, Lindstrom E, et al
    ODEVIXIBAT TREATMENT INDUCES BILIARY BILE ACID SECRETION IN RESPONSIVE PATIENTS WITH BILE SALT EXPORT PUMP DEFICIENCY (PFIC2).
    Gastroenterology. 2023 Mar 30:S0016-5085(23)00567.
    PubMed    


  72. EINER C, Munk DE, Park E, Akdogan B, et al
    ARBM101 (Methanobactin SB2) drains excess liver copper via biliary excretion in Wilson Disease rats.
    Gastroenterology. 2023 Mar 24:S0016-5085(23)00529.
    PubMed     Abstract available


  73. KO PH, Tseng CW
    An Unusual Cause of Acute Cholecystitis.
    Gastroenterology. 2023 Mar 23:S0016-5085(23)00531.
    PubMed    


  74. CHO SY, Hwang H, Kim YH, Yoo BC, et al
    Refining classification of cholangiocarcinoma subtypes via proteogenomic integration reveals new therapeutic prospects.
    Gastroenterology. 2023 Mar 8:S0016-5085(23)00237.
    PubMed     Abstract available


  75. JAYASEKERA CR, Barnhill M, Chascsa DM, Aqel B, et al
    Fenofibrate improves outcomes in ischemic cholangiopathy after liver transplantation.
    Gastroenterology. 2023 Mar 6:S0016-5085(23)00233.
    PubMed    


    February 2023
  76. FOGELSON KA, Dorrestein PC, Zarrinpar A, Knight R, et al
    The Gut Microbial Bile Acid Modulation and its Relevance to Digestive Health and Diseases.
    Gastroenterology. 2023 Feb 23:S0016-5085(23)00161.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Biliary Tract Diseases is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum